Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Esophageal Squamous Cell Carcinoma × ribociclib × 30 days × Clear all

Sponsor

Conditions

Breast Neoplasms 18 Neoplasm Metastasis 3 Neoplasms 2 Melanoma 2 Uterine Cervical Neoplasms 1 Unilateral Breast Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Solid Tumors 1 Recurrence 1 Ovarian Neoplasms 1 Neuroblastoma 1 Neoplasms by Site 1 Lung Neoplasms 1 Locoregional Recurrence 1 Hereditary Sensory and Autonomic Neuropathies 1 Head and Neck Neoplasms 1 Glioma 1 Glioblastoma 1 Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer 1 Endometrial Neoplasms 1 ER+ HER2- Advanced Breast Cancer 1 Diffuse Intrinsic Pontine Glioma 1 Colorectal Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms, Male 1 Breast Diseases 1 Brain Neoplasms 1 Astrocytoma 1

Interventions

pembrolizumab 7 Cisplatin 6 Paclitaxel 5 Drug Therapy 3 toripalimab 2 Radiotherapy 2 Irinotecan 2 Fluorouracil 2 Carboplatin 2 tislelizumab 1 regorafenib 1 osimertinib 1 nimotuzumab 1 lenvatinib 1 aflibercept 1 Oxaliplatin 1 Nivolumab 1 NEO212 1 Levoleucovorin 1 Leucovorin 1 Ipilimumab 1 IFL protocol 1 Histamine H2 Antagonists 1 Histamine Antagonists 1 Fulvestrant 1 Docetaxel 1 Dexamethasone 1 Chemoradiotherapy 1 Bevacizumab 1 Acetaminophen 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡